Related Experiment Video
Updated: Jul 11, 2026

Caspase-3 Activity in the Rat Amygdala Measured by Spectrofluorometry After Myocardial Infarction
Published on: January 12, 2016
Inhibitory cardiac transcription factor, SRF-N, is generated by caspase 3 cleavage in human heart failure and
Jiang Chang1, Lei Wei, Takayuki Otani
1Department of Molecular and Cellular Biology, Center for Cardiovascular Development, Methodist Hospital, Baylor College of Medicine, One Baylor Plaza, Houston, Tex 77030, USA.
Insights
In heart failure, caspase 3 cleaves serum response factor (SRF), creating a dominant-negative factor that suppresses cardiac genes. This SRF cleavage may be reversible with ventricular unloading.
Area of Science:
- Molecular biology
- Cardiovascular research
- Biochemistry
Background:
- Heart failure is characterized by reduced gene activity and modest caspase 3 activation.
- The role of the cardiac transcription factor serum response factor (SRF) in heart failure is not fully understood.
- We hypothesized that caspase 3 cleaves SRF, inhibiting its function and contributing to heart failure.
Purpose of the Study:
- To investigate whether serum response factor (SRF) is a cleavage target of caspase 3 in end-stage heart failure.
- To determine the functional consequences of SRF cleavage in the failing heart.
Main Methods:
- Analysis of SRF protein levels and fragmentation in human cardiac samples from heart failure patients and normal controls.
- Investigation of SRF fragmentation in patients with left ventricular assist devices.
- Identification of caspase 3 cleavage sites on SRF using antibodies and site-directed mutagenesis.
- Assessment of the transcriptional activity of SRF fragments in myogenic cells.
Main Results:
- Full-length SRF was significantly reduced and fragmented in failing hearts but intact in normal hearts.
- Minimal SRF fragmentation was observed in hearts with left ventricular assist devices.
- Two alternative caspase 3 cleavage sites were identified, generating N-terminal and C-terminal SRF fragments.
- Expression of the 32-kDa N-terminal SRF fragment (SRF-N) inhibited alpha-actin gene promoter activity by 50-60%.
Conclusions:
- Caspase 3 activation in heart failure sequentially cleaves SRF, producing a dominant-negative transcription factor.
- This process may explain the downregulation of cardiac-specific genes in heart failure.
- Caspase 3 activation and subsequent SRF cleavage might be reversible upon ventricular unloading.
Background:
Knowledge about molecular mechanisms leading to heart failure is still limited, but reduced gene activities and modest activation of caspase 3 are hallmarks of end-stage heart failure. We postulated that serum response factor (SRF), a central cardiac transcription factor, might be a cleavage target for modest activated caspase 3, and this cleavage of SRF may play a dominant inhibitory role in propelling hearts toward failure.
Methods And Results:
We examined SRF protein levels from cardiac samples taken at the time of transplantation in 13 patients with end-stage heart failure and 7 normal hearts. Full-length SRF was markedly reduced and processed into 55- and 32-kDa subfragments in all failing hearts. SRF was intact in normal samples. In contrast, the hearts of 10 patients with left ventricular assist devices showed minimal SRF fragmentation. Specific antibodies to N- and C-terminal SRF sequences and site-directed mutagenesis revealed 2 alternative caspase 3 cleavage sites, so that 2 fragments were detected of each containing either the N- or C-terminal SRF. Expression of SRF-N, the 32-kDa fragment, in myogenic cells inhibited the transcriptional activity of alpha-actin gene promoters by 50% to 60%, which suggests that truncated SRF functioned as a dominant-negative transcription factor.
Conclusions:
Caspase 3 activation in heart failure sequentially cleaved SRF and generated a dominant-negative transcription factor, which may explain the depression of cardiac-specific genes. Moreover, caspase 3 activation may be reversible in the failing heart with ventricular unloading.
Related Concept Videos
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Caspases
Rheumatic Heart Disease I: Introduction
Cardiomyopathy III: Hypertrophic Cardiomyopathy

